Hawley Opens Investigation into Abortion Drug Companies, Creates Hotline for Victims to Report Harms

For information about Senator Hawley’s new RECA law to compensate Missourians,click here.
Thursday, March 19, 2026
WASHINGTON— Today, U.S. Senator Josh Hawley (R-Mo.)sentletters to two chemical abortion drug manufacturers—Danco Laboratories and GenBioPro— to inform them that he is opening an investigation into their business practices related to mifepristone as mounting evidence shows women are suffering alarming rates of adverse-effects after taking the drug.“I write to inform you that I am opening an investigation into Danco Laboratories and its manufacture, distribution, and marketing practices relating to mifepristone. Mounting evidence suggests that mifepristone poses grave risks to women. Yet your company has continued to profit from the widespread distribution of this drug even as serious questions have emerged about hemorrhage, infection, sepsis, and other dangerous complications associated with its use.,”Senator Hawley wrote.Senator Hawley continued,“​These concerns are especially serious because as mifepristone became more widely distributed, your company was in a position to learn far more about the drug’s real-world consequences than the public. The larger the market for your product has become, the greater your access to adverse-event information, complication data, provider feedback, pharmacy complaints, and post-market safety signals. Yet serious questions remain about whether your company fully investigated those dangers and accurately conveyed them to regulators and the public. The success of your company’s mifepristone business depends on broad distribution and public confidence in the drug’s safety, so your company has a powerful financial incentive to avoid facts that could threaten sales, invite scrutiny, or justify stronger safeguards.”Senator Hawley concluded,“Congress must determine what your company knew about the harms associated with mifepristone, when it knew it, what it told regulators, and what it may have failed to disclose to women and the public. Accordingly, please produce the documents and information described in the attached Schedule by no later than April 24, 2026. The women exposed to the risks of this drug deserve a full accounting.”Read Senator Hawley’s full letter to the abortion drug companieshere.Senator Hawley is also opening a hotline for women who have been harmed by chemical abortion to confidentially share their stories with his office. Please contact Senator Hawley’s office by calling (202) 224-6154 or emailingAbortionDrugHarms@hawley.senate.gov.Senator Hawley recentlyhosteda press conference unveiling his newlegislationto ban the chemical abortion drug mifepristone and empower women harmed by the drug to sue its manufacturers.

"*" indicates required fields
381 Russell Senate Office BuildingWashington, D.C. 20510Office: 202-224-6154Fax: 202-228-0526
1123 Wilkes Blvd, Suite 220Columbia, MO 65201Office: 573-554-1919Fax: 573-256-1805
400 E. 9th Street, Suite 9350Kansas City, MO 64106Office: 816-960-4694Fax:816-472-6812
3236 E. Ridgeview StreetSpringfield, MO 65804Office: 417-869-4433
530 Maryville Centre DriveSuite 460St. Louis, MO 63141Office: 314-354-7060Fax: 1 314-436-8534
555 Independence Street, #1600Cape Girardeau, MO 63703Office: 573-334-5995Fax: 573-334-5947